Linda Mellbin Selected Research

Glucagon-Like Peptide Receptors

12/2019

Risk factor reduction in type 2 diabetes demands a multifactorial approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linda Mellbin Research Topics

Disease

19	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2008
16	Myocardial Infarction 01/2024 - 11/2006
11	Acute Coronary Syndrome 11/2023 - 09/2012
11	Heart Failure 01/2022 - 04/2010
9	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 07/2012
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2008
7	Glucose Intolerance 01/2024 - 07/2012
6	Insulin Resistance 11/2023 - 12/2015
5	Stroke (Strokes) 11/2021 - 01/2017
3	Body Weight (Weight, Body) 08/2023 - 01/2021
3	Hemorrhage 02/2022 - 01/2021
3	Diabetes Mellitus 01/2022 - 01/2014
3	Prediabetic State (Prediabetes) 01/2021 - 01/2008
2	Unstable Angina 11/2023 - 11/2022
2	Vascular Diseases (Vascular Disease) 01/2021 - 12/2019
2	Neoplasms (Cancer) 01/2018 - 01/2017
1	Out-of-Hospital Cardiac Arrest 06/2024
1	Microvascular Angina (Cardiac Syndrome X) 01/2023
1	Fatigue 01/2023
1	Cardiogenic Shock 02/2022
1	Glycosuria 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Hypotension (Low Blood Pressure) 01/2019
1	Non-ST Elevated Myocardial Infarction 09/2018
1	ST Elevation Myocardial Infarction 09/2018
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Rheumatoid Arthritis 01/2014
1	Glioblastoma (Glioblastoma Multiforme) 01/2014
1	Hypoglycemia (Reactive Hypoglycemia) 04/2010

Drug/Important Bio-Agent (IBA)

24	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 11/2006
5	empagliflozinIBA 11/2023 - 01/2021
5	Sitagliptin Phosphate (Januvia)FDA Link 08/2023 - 07/2014
4	Insulin (Novolin)FDA Link 11/2023 - 09/2012
4	aleglitazarIBA 01/2018 - 11/2014
3	semaglutideIBA 08/2023 - 01/2021
3	SymportersIBA 11/2022 - 01/2021
3	SodiumIBA 11/2022 - 01/2021
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 12/2019
2	C-PeptideIBA 11/2023 - 01/2022
2	Liraglutide FDA Link 08/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2015
2	Prasugrel Hydrochloride FDA Link 11/2021 - 01/2021
2	TicagrelorIBA 11/2021 - 01/2021
2	dulaglutideIBA 07/2021 - 01/2021
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021 - 01/2021
2	Insulin-Like Growth Factor Binding Protein 1IBA 01/2018 - 12/2015
2	AdiponectinIBA 01/2018 - 01/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 01/2018
2	Nonesterified Fatty Acids (NEFA)IBA 01/2018 - 09/2012
2	Arginine Vasopressin (Argipressin)IBA 02/2017 - 01/2016
2	Hormones (Hormone)IBA 02/2017 - 01/2015
2	Insulin-Like PeptidesIBA 01/2016 - 12/2015
1	Triglycerides (Triacylglycerol)IBA 01/2024
1	HDL CholesterolIBA 01/2024
1	Mannose (D-Mannose)IBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	dapagliflozinIBA 01/2022
1	Clopidogrel (Plavix)FDA Link 11/2021
1	omega-Chloroacetophenone (Mace)IBA 07/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Glucagon-Like Peptide ReceptorsIBA 12/2019
1	Oxygen (Dioxygen)IBA 11/2019
1	lipoprotein cholesterolIBA 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	Pioglitazone (Actos)FDA Link 01/2017
1	LeptinIBA 01/2017
1	AdipokinesIBA 01/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2015
1	Insulin-Like Growth Factor Binding ProteinsIBA 12/2015
1	LDL CholesterolIBA 06/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2015
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2015
1	AdrenomedullinIBA 01/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2015
1	Atrial Natriuretic Factor (ANF)IBA 01/2015
1	alogliptinIBA 11/2014
1	lixisenatideIBA 11/2014
1	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2014
1	human cytomegalovirus microRNA-UL112IBA 01/2014
1	CatecholaminesIBA 09/2012
1	PotassiumIBA 09/2012
1	Blood Glucose (Blood Sugar)IBA 01/2008

Therapy/Procedure

8	Therapeutics 11/2022 - 01/2008
3	Percutaneous Coronary Intervention 11/2021 - 09/2018
2	Glycemic Control 12/2015 - 04/2010
1	Resuscitation 06/2024
1	Counterpulsation (External Counterpulsation) 01/2023
1	Patient Readmission 11/2019
1	Conservative Treatment 09/2018
1	Heart Transplantation (Grafting, Heart) 02/2017
1	Heart-Assist Devices 02/2017
1	Drug Therapy (Chemotherapy) 06/2015
1	Catheters 04/2010
1	Secondary Prevention 04/2008